Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-14
2005-06-14
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S201000, C514S202000, C514S208000, C514S209000
Reexamination Certificate
active
06906054
ABSTRACT:
The invention provides pharmaceutical compositions comprising compounds of formula I and IV:wherein R1-R11and A have any of the values defined in the specification, and their pharmaceutically acceptable salts. The pharmaceutical compositions are useful for inhibiting β-lactamase enzymes, for enhancing the activity of β-lactam antibiotics, and for treating β-lactam resistant bacterial infections in a mammal.
REFERENCES:
patent: 4053468 (1977-10-01), Holden
patent: 4150156 (1979-04-01), Beattie et al.
patent: 4356174 (1982-10-01), Barth
patent: 4456755 (1984-06-01), Sheehan et al.
patent: 4459405 (1984-07-01), Hall
patent: 4512999 (1985-04-01), Adam-Molina et al.
patent: 4547371 (1985-10-01), Doherty et al.
patent: 4559157 (1985-12-01), Smith et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4637999 (1987-01-01), Doherty et al.
patent: 4820508 (1989-04-01), Wortzman
patent: 4826833 (1989-05-01), Chen
patent: 4861768 (1989-08-01), Torii et al.
patent: 4912213 (1990-03-01), Taniguchi et al.
patent: 4938949 (1990-07-01), Borch et al.
patent: 4992478 (1991-02-01), Geria
patent: 4992541 (1991-02-01), Blacklock et al.
patent: 5077286 (1991-12-01), Bissolino et al.
patent: 5126446 (1992-06-01), Brown, Jr. et al.
patent: 5258377 (1993-11-01), Maiti et al.
patent: 5264429 (1993-11-01), Maiti et al.
patent: 5348952 (1994-09-01), Bissolino et al.
patent: 5356888 (1994-10-01), Alpegiani et al.
patent: 5364848 (1994-11-01), Doherty et al.
patent: 5446037 (1995-08-01), Maiti et al.
patent: 5597817 (1997-01-01), Buynak et al.
patent: 5629306 (1997-05-01), Buynak et al.
patent: 5637579 (1997-06-01), Hubschwerlen et al.
patent: 5658567 (1997-08-01), Calhoun et al.
patent: 5681563 (1997-10-01), Buynak et al.
patent: 5760027 (1998-06-01), Buynak et al.
patent: 6156745 (2000-12-01), Buynak et al.
patent: 6303592 (2001-10-01), Buynak et al.
patent: 6391855 (2002-05-01), Blaschuk et al.
patent: 2708219 (1977-09-01), None
patent: 0041047 (1981-12-01), None
patent: 0041768 (1981-12-01), None
patent: 0050805 (1982-05-01), None
patent: 0120613 (1984-10-01), None
patent: 0150984 (1985-08-01), None
patent: 0170192 (1986-02-01), None
patent: 0210065 (1987-01-01), None
patent: 0337704 (1989-10-01), None
patent: 0367606 (1990-05-01), None
patent: 0043546 (1992-01-01), None
patent: 2043639 (1980-10-01), None
patent: 55-136288 (1980-10-01), None
patent: 57-99590 (1982-06-01), None
patent: 58-59990 (1983-04-01), None
patent: 61-109791 (1986-05-01), None
patent: 62-198687 (1987-09-01), None
patent: 64-66189 (1989-03-01), None
patent: 7-82273 (1995-03-01), None
patent: WO-91/09036 (1991-06-01), None
patent: WO-96/17848 (1996-06-01), None
patent: WO-96/17849 (1996-06-01), None
patent: WO-98/24793 (1998-06-01), None
patent: WO-00/63213 (2000-10-01), None
patent: WO-03/020732 (2003-03-01), None
Buynak, John.D. ,et al. ,“7-Alkylidenecephalosporin esters as Inhibitors of Human Leukocyte Elastase”,J. Med. Chem., vol. 40,(1997),pp. 3423-3433.
Applegate, H. E., et al., “7-[2-Hydroxyethyl]Cephalosporanic Acid Derivatives”,Tetrahedron Letters, 19, (1979), pp. 1637-1640.
Chandrasekaran, Srinivasan et al., “Synthesis of Substituted B-Lactams by Addition of Nitromethane to 6-Oxepenicillanates and 7-Oxocephalosporanates”,J. Org. Chem., vol. 42, No. 24,(1977), pp. 3972-3974.
Doherty, James B., et al., “Inhibition of human leukeocyte elastase. 1. Inhibition by C-7-substituted cephalosporin tert-Butyl esters”,J. Med. Chem., 33, (1990), pp. 2513-2521.
Finke, Paul E., et al., “Inhibition of human leukocyte Elastase. 4. Selection of a substituted cephalosporin (L-658,758) as a topical aerosol”,J. Med. Chem., 35, (1992), pp. 3731-3744.
Knight, W. B., et al., “Specificity, stability, and potency of monocyclic B-Lactam inhibitors of human leucocyte elastase”,Biochemistry, 31, (1992), pp. 8160-8170.
Navia, Manuel A., et al., “Crystallographic study of a B-lactam inhibitor complex with elastase at 1.84 A resolution”,Nature, 327, (1987), pp. 79-82.
Shah, Shrenik K., et al., “Inhibition of human leukocyte Elastase. 3. Synthesis and activity of 3'-substituted cephalosporins”,J. Med. Chem., 33, (1990), pp. 2529-2535.
Ursini, F., et al., “New Synthesis of 6-Oxopenicillanates by Ozonolysis of 6-Diazopenicillanates”,Synthesis, 4, (1992), pp. 363-364.
Uyeo, Shoichiro, et al., “Synthesis of (6R, 7R)-Phenylacetylmethyl-3-(1-Methyl-1H-Tetrazol-5-yl)Thiomethyl-1-)xa-1-Dethiacephalosporanic Acid”,Heterocycles, vol. 13,(1979), pp. 255-257.
Abd El-Nabi, H. A., “Novel Heterocycles: A convenient Synthesis of Pyrrolo [2,3-d]pyrazole; Cycloaddition reaction of N-aryl(methyl)pyrrol-2,3-Diones to diazomethane and olefins”,Tetrahedron, 53(5), (Feb. 1997),1813-1822.
Adam, Solange, “Synthesis of Methylene (R)-6-acetonylidene-3-methyl-7-oxo-4-thia-1-azabicyclo [3.2.0] hept-2-ene-carboxylate pivalate”,Heterocycles, 22(7), Columbus, Ohio, U.S.,(1984), 1509-1512.
Arisawa, M., et al., “6-Acetylmethylenepenicillanic Acid (Ro 15-1903), A Potent B-Lactamasae Inhibitor. I. Inhibition of Chromosomally and R-Factor-Mediated B-Lactamases”,The Journal of Antibiotics, 35(11), (Nov. 1982),1578-1583.
Beharry, Zanna, “Penicillin-Derived Inhibitors of the Class A B-Lactamase from Bacillus Anthracis”,ICAAC Poster # C1-679, Chicago, IL, (2003),6 pgs.
Bennett, I. S., et al., “6-(Substituted Methylene)Penems, Potent Broad Spectrum Inhibitors of Bacterial B-Lactamse. V. Chiral 1,2,3-Triazolyl Derivatives”,The Journal of Antibiotics, 44(9), (Sep. 1991),969-978.
Billups, W. E., et al., “Generation of Simple Methylenecyclopropenes as Reactive Intermediates”,Tetrahedron, 37, (1981),3215-3220.
Bitha, P., et al., “6-(1-Hydroxyalkyl)Penam Sulfone Derivatives as Inhibitors of Class A and Class C .beta.-Lactamases I”,Bioorganic & Medicinal Letters, 9(7), (1999),991-996.
Bitha, P., et al., “6-(1-Hydroxyalkyl)Penam Sulfone Derivatives as Inhibitors of Class A and Class C .beta.-Lactamases II”,Bioorganic & Medicinal Chemistry Letters, 9(7), (1999),997-1002.
Black, Jennifer, “Detection of Plasmid-Mediated AmpC B-Lactamases (pAmpCs) in Disk Tests Based on B-Lactamase Inhibitors (BLls) Ro 48-1220 (RO) and LN-2-128 (LN)”,43rd ICAAC Poster #D-258, (2003),6 pgs.
Blacklock, Thomas J., “A Versatile Synthesis of 1,1-Dioxo 7-Substituted Cephems: Preparation of the Human Leukocyte Elastase (HLE) Inhibitor 1,1-Dioxo-trans-7-methoxycephalosporanic Acid tert-Butyl Ester”,J. Org. Chem., 54, (1989),3907-3913.
Brenner, D. G., et al., “6-(Methoxymethylene)penicillanic Acid: Inactivator of RTEM B-Lactamse fromEscherichia coli”,Biochemistry, 23(24), (Nov. 20, 1984),5839-5846.
Buynak, John D., et al., “A Convenient Method for the Production of 6-Oxopenicillinates and 7-Oxocephalosporinates”,Tetrahedron Letters, 39, (1998),4945-4946.
Buynak, John D., et al., “a-Alkylidene B-Lactams. 2. A Formal Synthesis of (+)-Carpetimycin A”,J. Org. Chem., 51, (1986),1571-1574.
Buynak, John D., et al., “Catalytic Approaches to the Synthesis of B-Lactamase Inhibitors”,Tetrahedron, 56, (2000),5709-5718.
Buynak, J. D., et al., “Cephalosporin-Derived Inhibitors of beta-Lactamase. Part 4: The C3 Substituent”,Bioorganic & Medicinal Chemistry Letters, 12, Online Apr. 24, 2002,(2002),1663-1666.
Buynak, J. D., “Coupling Reactions of Cephalosporin Sulfones: A Stable 3-Stannylated Cephem”,Org. Lett. 2001, 3(19), (Aug. 30, 2001),2953-2956.
Buynak, John D., “Penicillin-Derived Inhibitors that Simultaneously Target Both Metallo-and Serine-B-Lactamases”,Bioorganic and Medicinal Chemistry Letters, (Article in Press, available online), (Jan. 22, 2004),6 pgs.
Buynak, John D., et al., “Reactions of (Silylamino)phosphines with Epoxides and Episulfides”,J. Org. Chem., 49, (1984),1828-1830.
Buynak, John D., et al., “Sti
Adam Greg C.
Buynak John D.
Doppalapudi Venkata Ramana
Nidamarthy Sirishkumar D.
Rao A. Srinivasa
Research Corporation Technologies Inc.
Spivack Phyllis G.
LandOfFree
Compositions for inhibiting beta-lactamase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for inhibiting beta-lactamase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for inhibiting beta-lactamase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3516736